Skip to main content

Peer Review reports

From: Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses

Original Submission
29 Feb 2012 Submitted Original manuscript
5 Mar 2012 Author responded Author comments - KEITH JONES
Resubmission - Version 2
5 Mar 2012 Submitted Manuscript version 2
25 Mar 2012 Reviewed Reviewer Report - Laurent Rivory
7 Apr 2012 Reviewed Reviewer Report - Mark McKeage
28 May 2012 Author responded Author comments - KEITH JONES
Resubmission - Version 3
28 May 2012 Submitted Manuscript version 3
Publishing
6 Nov 2012 Editorially accepted
21 Nov 2012 Article published 10.1186/1471-2407-12-536

You can find further information about peer review here.

Back to article page